Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, September 2003, p. 3015-3017, Vol. 47, No. 9
0066-4804/03/$08.00+0 DOI: 10.1128/AAC.47.9.3015-3017.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
and Theresa A. Shapiro*
Division of Clinical Pharmacology, Departments of Medicine and of Pharmacology and Molecular Sciences, The Johns Hopkins University, Baltimore, Maryland 21205
Received 11 March 2003/ Returned for modification 16 May 2003/ Accepted 4 June 2003
Fluoroquinolones with pyrrolidinyl substitutions were tested against Trypanosoma brucei and mammalian cells. Bulky substituents at C-7 or a 1-2-bridging thiazolidine ring increased antitrypanosomal activity and selective toxicity. These compounds trap protein-DNA complexes and inhibit nucleic acid biosynthesis in trypanosomes, characteristics of topoisomerase II inhibition.
Present address: Swiss Tropical Institute, Swiss Center for International Health, CH-4002 Basel, Switzerland.
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»